ACQUIRED PHIMOSIS

ACQUIRED PHIMOSIS was reported 119 times

ACQUIRED PHIMOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 1 0.0008
1 CD38-directed Cytolytic Antibody [EPC] 4 0.0007
2 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 30 0.0003
3 Glinide [EPC] 2 0.0002
4 Cephalosporin Antibacterial [EPC] 1 0.0001
5 Human Immunoglobulin G [EPC] 2 0.0001
6 Stimulant Laxative [EPC] 1 0.0001
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 5 0.0001
8 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
9 General Anesthetic [EPC] 2 0.0000
10 Nitrate Vasodilator [EPC] 4 0.0000
11 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
12 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
13 Antimycobacterial [EPC] 1 0.0000
14 Angiotensin Converting Enzyme Inhibitor [EPC] 5 0.0000
15 alpha-Adrenergic Blocker [EPC] 5 0.0000
16 Phenothiazine [EPC] 1 0.0000
17 Penem Antibacterial [EPC] 1 0.0000
18 Factor Xa Inhibitor [EPC] 8 0.0000
19 Tetracycline-class Drug [EPC] 2 0.0000
20 Rifamycin Antibacterial [EPC] 1 0.0000
21 Androgen Receptor Inhibitor [EPC] 2 0.0000
22 Azole Antifungal [EPC] 4 0.0000
23 Polyene Antifungal [EPC] 1 0.0000
24 Sulfonylurea [EPC] 3 0.0000
25 Thiazide-like Diuretic [EPC] 1 0.0000
26 Protease Inhibitor [EPC] 1 0.0000
27 Aminoglycoside Antibacterial [EPC] 1 0.0000
28 Muscle Relaxant [EPC] 1 0.0000
29 Vascular Endothelial Growth Factor Inhibitor [EPC] 4 0.0000
30 Insulin [EPC] 1 0.0000
31 Estrogen [EPC] 4 0.0000
32 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
33 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
34 Macrolide Antimicrobial [EPC] 1 0.0000
35 Loop Diuretic [EPC] 8 0.0000
36 Proteasome Inhibitor [EPC] 2 0.0000
37 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
38 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
39 beta-Adrenergic Blocker [EPC] 5 0.0000
40 Kinase Inhibitor [EPC] 9 0.0000
41 Insulin Analog [EPC] 7 0.0000
42 Dihydropyridine Calcium Channel Blocker [EPC] 5 0.0000
43 Nitroimidazole Antimicrobial [EPC] 1 0.0000
44 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
45 Nucleoside Metabolic Inhibitor [EPC] 4 0.0000
46 Cardiac Glycoside [EPC] 1 0.0000
47 Osmotic Laxative [EPC] 4 0.0000
48 Topoisomerase Inhibitor [EPC] 1 0.0000
49 Aldosterone Antagonist [EPC] 2 0.0000
50 Proton Pump Inhibitor [EPC] 7 0.0000
51 Nucleoside Analog Antiviral [EPC] 1 0.0000
52 Integrin Receptor Antagonist [EPC] 1 0.0000
53 Thalidomide Analog [EPC] 6 0.0000
54 Amide Local Anesthetic [EPC] 1 0.0000
55 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
56 Aminosalicylate [EPC] 1 0.0000
57 5-alpha Reductase Inhibitor [EPC] 1 0.0000
58 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
59 Platelet Aggregation Inhibitor [EPC] 5 0.0000
60 Corticosteroid [EPC] 11 0.0000
61 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
62 Fluoroquinolone Antibacterial [EPC] 1 0.0000
63 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
64 Opioid Agonist [EPC] 2 0.0000
65 Microtubule Inhibitor [EPC] 1 0.0000
66 RANK Ligand Inhibitor [EPC] 1 0.0000
67 Thiazide Diuretic [EPC] 1 0.0000
68 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
69 GLP-1 Receptor Agonist [EPC] 2 0.0000
70 Platinum-based Drug [EPC] 1 0.0000
71 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
72 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
73 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
74 Atypical Antipsychotic [EPC] 1 0.0000
75 Benzodiazepine [EPC] 1 0.0000